Home > Authorities > Institutes > Record #113731 |
G370
KKE NeuroonkologieID | I:(DE-He78)G370-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article (Review Article)
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
Neuro-Oncology 20(6), 743 - 752 (2018) [10.1093/neuonc/nox191]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
OncoTarget 9(47), 28772-28783 (2018) [10.18632/oncotarget.25594]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Neuro-Oncology 20(12), 1661 - 1671 (2018) [10.1093/neuonc/noy073]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
Acta neuropathologica 135(4), 639 - 642 (2018) [10.1007/s00401-018-1826-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.
Current opinion in oncology 30(6), 368-374 (2018) [10.1097/CCO.0000000000000478]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Correlated light and electron microscopy of cell division in large marine oocytes, eggs, and embryos.
Methods in cell biology 145, 293-313 (2018) [10.1016/bs.mcb.2018.03.031]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
Neuro-Oncology 20(11), 1517 - 1524 (2018) [10.1093/neuonc/noy134]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Neuro-Oncology 20(11), 1525 - 1535 (2018) [10.1093/neuonc/noy064]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
Acta neuropathologica 135(6), 955 - 963 (2018) [10.1007/s00401-018-1844-9]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI.
Neurology 5(5), e480 (2018) [10.1212/NXI.0000000000000480]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |